Ticker > Company >

Onesource Specialty share price

Onesource Specialty Pharma Ltd.

NSE: ONESOURCE BSE: 544292 SECTOR: Pharmaceuticals & Drugs  9.61 K   10   1

1853.00
+19.10 (1.04%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 1860

Today's Low

₹ 1821

52 Week High

₹ 2249.65

52 Week Low

₹ 1163.05

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

21221.52 Cr.

Enterprise Value

21722.9 Cr.

No. of Shares

11.45 Cr.

P/E

244.92

P/B

3.57

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  519.09

CASH

60.25 Cr.

DEBT

561.63 Cr.

Promoter Holding

29.79 %

EPS (TTM)

₹  7.57

Sales Growth

344.07%

ROE

-62.35 %

ROCE

-21.34%

Profit Growth

15.04 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year344.07%
3 YearNA
5 YearNA

Profit Growth

1 Year51.15%
3 YearNA
5 YearNA

ROE%

1 Year-62.35%

ROCE %

1 Year-21.34%

Debt/Equity

1.4407

Price to Cash Flow

-194.71

Interest Cover Ratio

-3.0813

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 29.79 25.01
Mar 2025 34.25 20.06
Dec 2024 37.77 9.58
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 275.061 Cr.
  • The company has an efficient Cash Conversion Cycle of -238.8177 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Promoter pledging has increased from 20.0634525384191% to 25.01% in 1 quarter.
  • Company has a poor ROCE of 0% over the past 3 years
  • Company has low Interest coverage ratio of -3.0813.
  • Company has negative cash flow from operations of -108.989.
  • Tax rate is low at 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 50.372.
  • Promoter pledging is high as 25.01%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 67.98 336.75 477.41 321.01
Total Expenditure 67.86 236.37 240.46 241.14
Operating Profit 0.12 100.38 236.96 79.88
Other Income 0.58 5.01 3.91 5.26
Interest 20.71 43.92 32.39 27.03
Depreciation 19.06 33.98 33.59 33.28
Exceptional Items -0.95 -100.52 0 0
Profit Before Tax -40.02 -73.02 174.88 24.82
Tax 0 0 0 0
Profit After Tax -40.02 -73.02 174.88 24.82
Adjusted EPS (Rs) -9.63 -6.38 15.28 2.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024
Net Sales 38.71 171.92
Total Expenditure 199.33 259.44
Operating Profit -160.62 -87.52
Other Income 2.7 4.23
Interest 47.55 89.42
Depreciation 65.68 76.29
Exceptional Items -158.41 -115.93
Profit Before Tax -429.55 -364.93
Tax 0 0
Net Profit -799.11 -390.4
Adjusted EPS (Rs.) -107.12 -91.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.01 4.01
Total Reserves 782.7 393.73
Borrowings 334.88 271.59
Other N/C liabilities 23.27 10.72
Current liabilities 863.59 628.52
Total Liabilities 2008.44 1308.58
Assets
Net Block 1361.33 862.59
Capital WIP 191.23 42.74
Intangible WIP 143.24 145.29
Investments 0.01 3.91
Loans & Advances 82 76.84
Other N/C Assets 2.42 0.8
Current Assets 228.21 176.42
Total Assets 2008.44 1308.58
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024
Profit from operations -799.11 -390.4
Adjustment 604.94 288.08
Changes in Assets & Liabilities 18.55 -6.66
Tax Paid 10.93 0
Operating Cash Flow -164.7 -108.99
Investing Cash Flow -65.68 505.99
Financing Cash Flow 118.32 -384.22
Net Cash Flow -112.06 12.78

Corporate Actions

Investors Details

PARTICULARS Dec 2024% Mar 2025% Jun 2025%
promoters 37.77 34.25 29.79
aditya arun kumar 0.03 0.03 0.03
arco lab private limited 1.61 1.61 1.61
arun kumar pillai 0.85 0.85 0.85
karuna business solutions... 6.89 6.89 6.89
padmakumar karunakaran pi... 0.08 - 0.04
pronomz ventures llp 7.31 6.80 2.34
rajitha gopalakrishnan 0.03 0.03 0.03
sajitha pillai 0.04 0.03 0.03
tenshi pharmaceuticals pr... 20.82 17.94 17.93
vineetha mohanakumar pill... 0.08 - 0.04
padmakumar karunakara pil... - 0.04 -
vineetha mohankumar pilla... - 0.04 -
hemalatha pillai 0.03 - -
PARTICULARS Dec 2024% Jun 2025%
investors 62.23 70.21
360 one special opportuni... - 1.62
amansa holdings private l... - 3.31
authum investment and inf... - 5.18
axis mutual fund - 1.01
investor education and pr... 0.06 0.06
motilal oswal - 3.20
mukul mahavir agrawal - 1.14
nova global opportunities... - 1.39
quant mutual fund - 2.17
route one fund i, l.p. - 2.07
route one offshore master... - 2.33
sbi life insurance co. lt... - 1.40
smallcap world fund, inc - 1.36
think investments pcc - 2.02
timf holdings - 2.20

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q3FY25
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Onesource Specialty - Quaterly Results 4 Aug, 8:26 PM Onesource Specialty - Quaterly Results 4 Aug, 8:26 PM Onesource Specialty Pharma informs about disclosures 16 Jun, 4:07 PM OneSource partners with Xbrane Biopharma AB for biosimilars manufacturing 11 Jun, 5:43 PM OneSource Specialty Pharma informs about press release 11 Jun, 10:12 AM OneSource Specialty Pharma’s Bangalore facility gets VAI classification from USFDA 10 Jun, 11:14 AM Onesource Specialty Pharma informs about update 10 Jun, 9:47 AM OneSource Specialty Pharma informs about disclosure 30 May, 5:37 PM Onesource Specialty - Quaterly Results 5 May, 8:24 PM Onesource Specialty - Quaterly Results 5 May, 8:24 PM OneSource Specialty Pharma informs about press release 10 Apr, 12:44 PM OneSource Specialty Pharma gets GMP certification for flagship unit 2 facility 10 Apr, 11:44 AM OneSource Specialty Pharma gets four observations from USFDA for Bangalore facility 31 Mar, 2:58 PM Onesource Specialty Pharma informs about disclosure 31 Jan, 5:24 PM Onesource Specialty Pharma informs about conference call 30 Jan, 2:55 PM Onesource Specialty Pharma informs about conference call 30 Jan, 2:51 PM OneSource Specialty Pharma informs about press release 29 Jan, 9:34 AM OneSource Specialty gets EIR with VAI status for BLD facility in Bangalore 29 Jan, 9:29 AM Onesource Specialty - Quaterly Results 29 Jan, 7:42 AM Onesource Specialty - Quaterly Results 29 Jan, 7:42 AM Onesource Specialty - Quaterly Results 29 Jan, 7:42 AM OneSource Specialty Pharma informs about shareholding pattern 25 Jan, 9:43 AM OneSource Specialty Pharma informs about financial results 25 Jan, 9:42 AM Onesource Specialty - Quaterly Results 25 Jan, 12:11 AM

Onesource Specialty Stock Price Analysis and Quick Research Report. Is Onesource Specialty an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Onesource Specialty. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Onesource Specialty has a PE ratio of 242.908879431124 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Onesource Specialty has ROA of -22.0037% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Onesource Specialty has a Current ratio of 0.2807.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Onesource Specialty has a ROE of -62.3508%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Onesource Specialty has a Debt to Equity ratio of 1.4407 which means that the company has low proportion of debt in its capital.

  • Sales growth: Onesource Specialty has reported revenue growth of 344.0745% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Onesource Specialty for the current financial year is -50.9053682257342%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Onesource Specialty is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Onesource Specialty is Rs 7.5658. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Onesource Specialty in Ticker for free. Also, one can get the intrinsic value of Onesource Specialty by using Valuation Calculators, which are available with a Finology ONE subscription. 

Onesource Specialty FAQs

Q1. What is Onesource Specialty share price today?
Ans: The current share price of Onesource Specialty is Rs 1837.8.

Q2. What is the market capitalisation of Onesource Specialty?
Ans: Onesource Specialty has a market capitalisation of Rs 21047.44419648 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Onesource Specialty?
Ans: The PE ratio of Onesource Specialty is 242.908879431124 and the P/B ratio of Onesource Specialty is 3.54040469033306, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Onesource Specialty share?
Ans: The 52-week high share price of Onesource Specialty is Rs 2248, and the 52-week low share price of Onesource Specialty is Rs 1209.95.

Q5. Does Onesource Specialty pay dividends?
Ans: Currently, Onesource Specialty does not pay dividends. Dividend yield of Onesource Specialty is around 0%.

Q6. What are the face value and book value of Onesource Specialty shares?
Ans: The face value of Onesource Specialty shares is Rs 1, while the book value per share of Onesource Specialty is around Rs 519.0932. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Onesource Specialty?
Ans: Onesource Specialty has a total debt of Rs 561.63 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Onesource Specialty?
Ans: The ROE of Onesource Specialty is -62.3508% and ROCE of Onesource Specialty is -21.335%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Onesource Specialty a good buy for the long term?
Ans: The Onesource Specialty long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Onesource Specialty undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Onesource Specialty appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Onesource Specialty’s financials?
Ans: You can review Onesource Specialty’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Onesource Specialty
X